Trial of Erythropoietin for Hypoxic–Ischemic Encephalopathy in Newborns
- DOI
- 10.1056/nejmoa2119660
- Published
- 2022-07-14
- Container
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1056/nejmoa2119660,
title = {Trial of Erythropoietin for Hypoxic–Ischemic Encephalopathy in Newborns},
author = {Yvonne W. Wu and Bryan A. Comstock and Fernando F. Gonzalez and Dennis E. Mayock and Amy M. Goodman and Nathalie L. Maitre and Taeun Chang and Krisa P. Van Meurs and Andrea L. Lampland and Ellen Bendel-Stenzel and Amit M. Mathur and Tai-Wei Wu and David Riley and Ulrike Mietzsch and Lina Chalak and John Flibotte and Joern-Hendrik Weitkamp and Kaashif A. Ahmad and Toby D. Yanowitz and Mariana Baserga and Brenda B. Poindexter and Elizabeth E. Rogers and Jean R. Lowe and Karl C.K. Kuban and T. Michael O’Shea and Jessica L. Wisnowski and Robert C. McKinstry and Stefan Bluml and Sonia Bonifacio and Kristen L. Benninger and Rakesh Rao and Christopher D. Smyser and Gregory M. Sokol and Stephanie Merhar and Michael D. Schreiber and Hannah C. Glass and Patrick J. Heagerty and Sandra E. Juul},
year = {2022},
journal = {New England Journal of Medicine},
doi = {10.1056/nejmoa2119660},
url = {https://doi.org/10.1056/nejmoa2119660}
}RIS
TY - JOUR TI - Trial of Erythropoietin for Hypoxic–Ischemic Encephalopathy in Newborns AU - Yvonne W. Wu AU - Bryan A. Comstock AU - Fernando F. Gonzalez AU - Dennis E. Mayock AU - Amy M. Goodman AU - Nathalie L. Maitre AU - Taeun Chang AU - Krisa P. Van Meurs AU - Andrea L. Lampland AU - Ellen Bendel-Stenzel AU - Amit M. Mathur AU - Tai-Wei Wu AU - David Riley AU - Ulrike Mietzsch AU - Lina Chalak AU - John Flibotte AU - Joern-Hendrik Weitkamp AU - Kaashif A. Ahmad AU - Toby D. Yanowitz AU - Mariana Baserga AU - Brenda B. Poindexter AU - Elizabeth E. Rogers AU - Jean R. Lowe AU - Karl C.K. Kuban AU - T. Michael O’Shea AU - Jessica L. Wisnowski AU - Robert C. McKinstry AU - Stefan Bluml AU - Sonia Bonifacio AU - Kristen L. Benninger AU - Rakesh Rao AU - Christopher D. Smyser AU - Gregory M. Sokol AU - Stephanie Merhar AU - Michael D. Schreiber AU - Hannah C. Glass AU - Patrick J. Heagerty AU - Sandra E. Juul PY - 2022 JO - New England Journal of Medicine DO - 10.1056/nejmoa2119660 UR - https://doi.org/10.1056/nejmoa2119660 ER -
APA
Wu, Y. W., Comstock, B. A., Gonzalez, F. F., Mayock, D. E., Goodman, A. M., Maitre, N. L., Chang, T., Meurs, K. P. V., Lampland, A. L., Bendel-Stenzel, E., Mathur, A. M., Wu, T., Riley, D., Mietzsch, U., Chalak, L., Flibotte, J., Weitkamp, J., Ahmad, K. A., Yanowitz, T. D., Baserga, M., Poindexter, B. B., Rogers, E. E., Lowe, J. R., Kuban, K. C., O’Shea, T. M., Wisnowski, J. L., McKinstry, R. C., Bluml, S., Bonifacio, S., Benninger, K. L., Rao, R., Smyser, C. D., Sokol, G. M., Merhar, S., Schreiber, M. D., Glass, H. C., Heagerty, P. J., & Juul, S. E. (2022). Trial of Erythropoietin for Hypoxic–Ischemic Encephalopathy in Newborns. New England Journal of Medicine. https://doi.org/10.1056/nejmoa2119660
Source records
- crossref · retrieved 2026-09-26T11:20:44.264Z